DK519488D0 - Substituerede pyridiner, fremgangsmaader til fremstilling heraf, mellemprodukter, som er anvendelige ved deres fremstilling samt farmaceutiske midler indeholdende dem - Google Patents

Substituerede pyridiner, fremgangsmaader til fremstilling heraf, mellemprodukter, som er anvendelige ved deres fremstilling samt farmaceutiske midler indeholdende dem

Info

Publication number
DK519488D0
DK519488D0 DK519488A DK519488A DK519488D0 DK 519488 D0 DK519488 D0 DK 519488D0 DK 519488 A DK519488 A DK 519488A DK 519488 A DK519488 A DK 519488A DK 519488 D0 DK519488 D0 DK 519488D0
Authority
DK
Denmark
Prior art keywords
procedures
preparation
production
pharmaceutical agents
agents containing
Prior art date
Application number
DK519488A
Other languages
English (en)
Other versions
DK519488A (da
Inventor
Lawrence Ivan Kruse
Stephen Torey Ross
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK519488D0 publication Critical patent/DK519488D0/da
Publication of DK519488A publication Critical patent/DK519488A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK519488A 1987-09-17 1988-09-16 Substituerede pyridiner, fremgangsmaader til fremstilling heraf, mellemprodukter, som er anvendelige ved deres fremstilling samt farmaceutiske midler indeholdende dem DK519488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/097,988 US4839371A (en) 1987-09-17 1987-09-17 3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors

Publications (2)

Publication Number Publication Date
DK519488D0 true DK519488D0 (da) 1988-09-16
DK519488A DK519488A (da) 1989-03-18

Family

ID=22266083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK519488A DK519488A (da) 1987-09-17 1988-09-16 Substituerede pyridiner, fremgangsmaader til fremstilling heraf, mellemprodukter, som er anvendelige ved deres fremstilling samt farmaceutiske midler indeholdende dem

Country Status (6)

Country Link
US (1) US4839371A (da)
EP (1) EP0308159A3 (da)
JP (1) JPH01104053A (da)
AU (1) AU2223088A (da)
DK (1) DK519488A (da)
PT (1) PT88509A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308854A (en) * 1990-06-18 1994-05-03 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
DE602004023106D1 (de) 2003-11-07 2009-10-22 Senju Pharma Co Pharmazeutische zusammensetzung mit prostaglandin
EP2822936B1 (en) 2012-03-07 2021-09-08 The McLean Hospital Corporation Aminoquinoline derivatives and uses thereof
KR102172771B1 (ko) 2020-06-16 2020-11-02 주식회사 세화 개별 검지 기능을 갖는 led 신호기 및 이를 이용한 신호 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7016899A (da) * 1969-12-03 1971-06-07
US3853900A (en) * 1973-09-14 1974-12-10 Searle & Co 4-benzyloxy-2 (1h)-pyridones
US4487761A (en) * 1982-04-05 1984-12-11 Merck & Co., Inc. Dopamine β-hydroxylase inhibitors
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives

Also Published As

Publication number Publication date
AU2223088A (en) 1989-03-23
EP0308159A2 (en) 1989-03-22
JPH01104053A (ja) 1989-04-21
PT88509A (pt) 1989-07-31
US4839371A (en) 1989-06-13
EP0308159A3 (en) 1990-01-10
DK519488A (da) 1989-03-18

Similar Documents

Publication Publication Date Title
NO871602L (no) 1-hydroksy-2-pyridoner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem samt ved fremstillingen av 1-hydroksy-2-pyridoner dannede mellomprodukter.
DK568285D0 (da) 1,4-dihydropyridiner, deres fremstilling og mellemprodukter hertil samt deres anvendelse som laegemidler
DK578585A (da) Aminoacyllabdaner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse som laegemidler
DK656588A (da) Substituerede hydroxylaminer, deres fremstilling og anvendelse som laegemidler, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DK539087D0 (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK135988A (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
DK303688A (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK55188A (da) Alkylsubstituerede n-benzopyranyllactamer, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK536488D0 (da) Alkadienderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt laegemidler deraf
DK93986D0 (da) Substituerede benzimidazolderivater, fremgangsmaader til fremstillingheraf, mellemprodukter, der er anvendelige ved deres fremstilling samt farmaceutiske midler indeholdende dem
DK419887D0 (da) Triazolopyrimidin-2-sulfonamider, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse som herbicider
DK163121C (da) 1-benzazepin-2-on-derivater, farmaceutiske praeparater indeholdende saadanne samt anvendelse af dem til fremstilling af praeparaterne
DK393788A (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK361288D0 (da) Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling
DK519488D0 (da) Substituerede pyridiner, fremgangsmaader til fremstilling heraf, mellemprodukter, som er anvendelige ved deres fremstilling samt farmaceutiske midler indeholdende dem
DK401988A (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO882065D0 (no) Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse, samt legemidler som inneholder denne.
DK222888A (da) Anellerede heteroalkylenquinolinaminer, isomere og salte deraf, deres fremstilling og anvendelse som laegemidler smat mellemprodukter til fremstillingen
DK11089A (da) 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
DK562686A (da) 2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen
DK439789D0 (da) Ethansulfonamidforbindelser, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende samme samt mellemprodukter til anvendelse ved fremgangsmaaden
NO880628D0 (no) Annelerte azepinon- og azocinon-derivater, fremgangsmaaaate til deresfremstilling, midler som inneholder dem og deres anvendelse samt mellomprodukter ved deres fremstilling.
DK135288A (da) Thiazolylderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
DK348388D0 (da) Sulfonylurinstofforbindelser, fremgangsmaade til deres fremstilling, samt deres anvendelser som ukrudtsbekaempelsesmidler
DK570388A (da) Pyridylphosphater, fremgangsmaade til deres fremstilling samt deres anvendelse som pesticider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment